Home/Pipeline/SIILTIBCY®

SIILTIBCY®

Tuberculosis Diagnosis

Approved/CommercialActive

Key Facts

Indication
Tuberculosis Diagnosis
Phase
Approved/Commercial
Status
Active
Company

About Bilthoven Biologicals

Bilthoven Biologicals is a well-established, mission-driven vaccine manufacturer with a century-long history, now operating as a strategic European arm of the Serum Institute of India. The company leverages its manufacturing expertise and global partnerships to produce and develop vaccines aimed at increasing global accessibility and pandemic preparedness. Its recent milestones include opening new pandemic preparedness facilities and gaining European marketing authorization for a novel tuberculosis diagnostic, positioning it as a key player in global public health.

View full company profile

Therapeutic Areas

Other Tuberculosis Diagnosis Drugs

DrugCompanyPhase
Anti-Mtb Diagnostic AntibodiesAustrianniDevelopment
Tuberculosis KitICHORtecPre-clinical